T. Rowe Price Investment Management, Inc. Bio N Tech Se Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 86,154 shares of BNTX stock, worth $9.16 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
86,154
Previous 53,336
61.53%
Holding current value
$9.16 Million
Previous $6.08 Million
29.09%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
340Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$868 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$453 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$430 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$202 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$192 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...